Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Comparative Neurology
|
January 18, 2003
PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures
Robert P Brendza, Cara O'Brien, Kelly Simmons, et al.
Biochemistry
|
August 31, 2012
BMS-708,163 targets presenilin and lacks notch-sparing activity
Christina J Crump, Suita V Castro, Feng Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 16, 2012
Development of clickable active site-directed photoaffinity probes for γ-secretase
Christina J Crump, Christopher W am Ende, T Eric Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2004
Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein
Celina V Zerbinatti, David F Wozniak, John Cirrito, et al.
Neurobiology of Aging
|
May 30, 2006
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms
David A Costa, Jennifer R Cracchiolo, Adam D Bachstetter, et al.
Brain Research. Molecular Brain Research
|
May 17, 2005
NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells
Yansheng Du, Xianming Chen, Xing Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2002
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
Ronald B DeMattos, Mark A O'dell, Maia Parsadanian, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
The Journal of Biological Chemistry
|
February 12, 2013
γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin
Nikolay Pozdnyakov, Heather E Murrey, Christina J Crump, et al.
Neuron
|
December 21, 2005
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo
John R Cirrito, Kelvin A Yamada, Mary Beth Finn, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Comparative Neurology
|
January 18, 2003
PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures
Robert P Brendza, Cara O'Brien, Kelly Simmons, et al.
Biochemistry
|
August 31, 2012
BMS-708,163 targets presenilin and lacks notch-sparing activity
Christina J Crump, Suita V Castro, Feng Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 16, 2012
Development of clickable active site-directed photoaffinity probes for γ-secretase
Christina J Crump, Christopher W am Ende, T Eric Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2004
Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein
Celina V Zerbinatti, David F Wozniak, John Cirrito, et al.
Neurobiology of Aging
|
May 30, 2006
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms
David A Costa, Jennifer R Cracchiolo, Adam D Bachstetter, et al.
Brain Research. Molecular Brain Research
|
May 17, 2005
NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells
Yansheng Du, Xianming Chen, Xing Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2002
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
Ronald B DeMattos, Mark A O'dell, Maia Parsadanian, et al.
The American Journal of Pathology
|
October 7, 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
Anne M Fagan, Erin Christopher, Jennie W Taylor, et al.
The Journal of Biological Chemistry
|
February 12, 2013
γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin
Nikolay Pozdnyakov, Heather E Murrey, Christina J Crump, et al.
Neuron
|
December 21, 2005
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo
John R Cirrito, Kelvin A Yamada, Mary Beth Finn, et al.
Page
of 7